As equities stumbled in Q1 2025, gold surged to new highs, reinforcing its role as a powerful diversifier amid shifting ...

Phil King discusses the Opthea fiasco, his current outlook and whether we’ve seen the bottom in equity markets.

Franklin FTSE Saudi Arabia ETF is currently witnessing strong bearish momentum, and its valuations are pricey. Read why FLSA ...

The good news for investors seeking high-yield dividend stocks to buy right now is that there are a number of top options for ...

VeChain (VET) faces renewed selling pressure, with the price testing key support levels. Could $0.018 be the next target for ...

Bitcoin continues to trade within a relatively narrow range of $83K–$86K, hovering around the 50-day moving average.

The rally is still early, but it’s gaining traction. The stock’s relative strength index (RSI) is climbing steadily out of ...

The tech-laden Nasdaq Composite index has dropped more than 20% in 2025 (as of this writing). Fears of an economic slowdown and a potential recession have led investors to book profits in stocks that ...

Hedera (HBAR) went down by 5.6% on Sunday. Is a bigger crash coming or will the token keep rallying? Find out here.

The Mantra team has cleared the air on the collapse, but traders remain cautious on the sidelines awaiting a post-mortem report.

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Microsoft Corporation. Read 's Market Analysis on Investing.com ...